null

AGX101 Biosimilar (Anti-TM4SF1) Antibody (HDBS0139)

SKU:
HDBS0139
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
TM4SF1
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
$479
Frequently bought together:

Description

system_update_altDatasheet

AGX101 (Anti-TM4SF1) Biosimilar Antibody (HDBS0139)

The AGX101 Biosimilar Anti-TM4SF1 Antibody is a cutting-edge research tool designed for studies involving TM4SF1, a transmembrane protein associated with cancer progression and metastasis. This monoclonal antibody, produced using advanced biotechnologies, specifically targets and binds to the TM4SF1 protein, allowing for precise detection and analysis in various experimental settings.TM4SF1, also known as a tumor-associated antigen, is overexpressed in numerous cancer types and is linked to increased tumor invasiveness and resistance to therapy. Understanding the role of TM4SF1 in cancer biology is crucial for developing targeted therapies and personalized treatment strategies for patients with aggressive tumors.

The AGX101 Biosimilar Anti-TM4SF1 Antibody is highly specific and sensitive, making it an invaluable asset for researchers investigating the molecular mechanisms underlying cancer progression and metastasis. Its compatibility with diverse research techniques, such as immunohistochemistry and flow cytometry, provides flexibility in experimental design and data interpretation. By utilizing this innovative antibody, scientists can further elucidate the complex functions of TM4SF1 and pave the way for novel therapeutic interventions in the fight against cancer.